| Molecular mechanisms of insulin resistance and associated diseases B Mlinar, J Marc, A Janež, M Pfeifer Clinica chimica acta 375 (1-2), 20-35, 2007 | 568 | 2007 |
| Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10) MS Capehorn, AM Catarig, JK Furberg, A Janez, HC Price, S Tadayon, ... Diabetes & metabolism 46 (2), 100-109, 2020 | 353 | 2020 |
| Once-weekly insulin for type 2 diabetes without previous insulin treatment J Rosenstock, HS Bajaj, A Janež, R Silver, K Begtrup, MV Hansen, T Jia, ... New England Journal of Medicine 383 (22), 2107-2116, 2020 | 207 | 2020 |
| Insulin therapy in adults with type 1 diabetes mellitus: a narrative review A Janež, C Guja, A Mitrakou, N Lalic, T Tankova, L Czupryniak, AG Tabák, ... Diabetes Therapy 11, 387-409, 2020 | 200 | 2020 |
| Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin M Jensterle Sever, T Kocjan, M Pfeifer, NA Kravos, A Janez European journal of endocrinology 170 (3), 451-459, 2014 | 181 | 2014 |
| Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport R Herman, NA Kravos, M Jensterle, A Janež, V Dolžan International journal of molecular sciences 23 (3), 1264, 2022 | 177 | 2022 |
| Female rats do not exhibit free fatty acid–induced insulin resistance A Hevener, D Reichart, A Janez, J Olefsky Diabetes 51 (6), 1907-1912, 2002 | 156 | 2002 |
| Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review M Jensterle, M Rizzo, M Haluzík, A Janež Advances in therapy 39 (6), 2452-2467, 2022 | 151 | 2022 |
| Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes G Schernthaner, N Shehadeh, AS Ametov, AV Bazarova, F Ebrahimi, ... Cardiovascular diabetology 19, 1-17, 2020 | 151 | 2020 |
| Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study V Salamun, M Jensterle, A Janez, E Vrtacnik Bokal European journal of endocrinology 179 (1), 1-11, 2018 | 145 | 2018 |
| Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe—recommendations from the international Central-Eastern European … L Czupryniak, L Barkai, S Bolgarska, A Bronisz, J Broz, K Cypryk, ... Diabetes technology & therapeutics 16 (7), 460-475, 2014 | 125 | 2014 |
| Thiazolidinedione treatment prevents free fatty acid–induced insulin resistance in male wistar rats AL Hevener, D Reichart, A Janez, J Olefsky Diabetes 50 (10), 2316-2322, 2001 | 115 | 2001 |
| Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus M Lunder, M Janić, M Japelj, A Juretič, A Janež, M Šabovič Cardiovascular diabetology 17, 1-8, 2018 | 111 | 2018 |
| A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed … M Jensterle, NA Kravos, M Pfeifer, T Kocjan, A Janez Hormones 14 (1), 81-90, 2015 | 104 | 2015 |
| Atherosclerosis development and progression: the role of atherogenic small, dense LDL J Vekic, A Zeljkovic, AFG Cicero, A Janez, AP Stoian, A Sonmez, M Rizzo Medicina 58 (2), 299, 2022 | 95 | 2022 |
| The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective M Jensterle, A Janez, E Fliers, JH DeVries, E Vrtacnik-Bokal, ... Human reproduction update 25 (4), 504-517, 2019 | 95 | 2019 |
| Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial M Jensterle, NA Kravos, K Goričar, A Janez BMC endocrine disorders 17, 1-6, 2017 | 84 | 2017 |
| Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome M Jensterle, M Sebestjen, A Janez, J Prezelj, T Kocjan, I Keber, M Pfeifer European journal of endocrinology 159 (4), 399-406, 2008 | 84 | 2008 |
| Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study M Jensterle, V Salamun, T Kocjan, E Vrtacnik Bokal, A Janez Journal of ovarian research 8, 1-8, 2015 | 81 | 2015 |
| Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome M Jensterle, T Kocjan, NA Kravos, M Pfeifer, A Janez Endocrine research 40 (3), 133-138, 2015 | 78 | 2015 |
